Previous studies have demonstrated the role of the PPARγ/PGC-1α pathway in inhibiting obesity, delaying the progression of chronic obstructive pulmonary disease, and attenuating pulmonary edema [18, 38, 39]. Here, PPARG is linked to obesity disorder.